Abstract
Ischemic stroke and myocardial infarction (MI) are among the leading causes of morbidity and mortality globally. Recent research has increasingly highlighted the significant interrelation between these two vascular events, emphasizing shared pathophysiological mechanisms, overlapping risk factors, and complex clinical outcomes. This review explores the multifaceted relationship between ischemic stroke and MI, focusing on their common underlying mechanisms, including atherosclerosis, thromboembolism, inflammation, and endothelial dysfunction. Both conditions often co-occur due to their shared risk factors, such as hypertension, diabetes, and smoking, leading to compounded health risks for affected individuals. This review aims to synthesize current evidence on the epidemiological, pathophysiological, and clinical interrelationships between ischemic stroke and myocardial infarction, highlighting practical clinical implications and areas for future research. Although ischemic stroke and myocardial infarction primarily affect distinct organ systems, atypical presentations and shared systemic effects can occasionally complicate diagnosis. Cardiac complications are common in acute ischemic stroke, while stroke-like symptoms may arise in patients with acute MI, especially when silent infarctions occur. This diagnostic challenge underscores the need for advanced neuroimaging and cardiac imaging modalities, alongside biomarkers like D-dimer, BNP, and troponins, to enhance early detection and guide therapeutic decisions. Therapeutic strategies for patients with both conditions must be comprehensive, combining acute management with long-term secondary prevention. While antiplatelet therapy, thrombolysis, and anticoagulation are essential in the acute phase, long-term management involves a focus on controlling cardiovascular risk factors, such as blood pressure and cholesterol, and promoting lifestyle modifications. The role of interdisciplinary care-particularly collaboration between cardiology and neurology-is essential for improving outcomes and minimizing complications. The intersection of ischemic stroke and MI presents significant clinical challenges but also opportunities for enhanced patient management. Integrated diagnostic approaches, personalized treatments, and further research into molecular mechanisms are vital for improving the prognosis of individuals affected by both conditions.